Cash & equivalents increased 72.4%
Cash & equivalents changed +72.4% from the comparable as-filed period. The change ranks at the 95th percentile of 100 prior comparable changes.
$279.7M→$482.3M100 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →STE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Debt decreased 13.3%
Debt changed -13.3% from the comparable as-filed period. The change ranks at the 46th percentile of 50 prior comparable changes.
$1.9B→$1.7B50 prior comparisons
Free-cash-flow proxy decreased 14.3%
Free-cash-flow proxy changed -14.3% from the comparable as-filed period. The change ranks at the 39th percentile of 33 prior comparable changes.
$326.4M→$279.6M33 prior comparisons
Net income increased 12.8%
Net income changed +12.8% from the comparable as-filed period. The change ranks at the 25th percentile of 57 prior comparable changes.
$177.4M→$200.1M57 prior comparisons
Operating cash flow decreased 12.6%
Operating cash flow changed -12.6% from the comparable as-filed period. The change ranks at the 39th percentile of 33 prior comparable changes.
$420.0M→$367.1M33 prior comparisons
Operating income increased 16.2%
Operating income changed +16.2% from the comparable as-filed period. The change ranks at the 44th percentile of 57 prior comparable changes.
$246.0M→$285.8M57 prior comparisons
Capex / revenue moved 87 bp lower
Capex / revenue changed -87 basis points from the comparable as-filed period. The change ranks at the 39th percentile of 33 prior comparable changes.
6.73%→5.86%33 prior comparisons
Capital expenditure decreased 6.5%
Capital expenditure changed -6.5% from the comparable as-filed period. The change ranks at the 21th percentile of 33 prior comparable changes.
$93.6M→$87.5M33 prior comparisons
Gross profit increased 8.9%
Gross profit changed +8.9% from the comparable as-filed period. The change ranks at the 51th percentile of 57 prior comparable changes.
$628.0M→$684.2M57 prior comparisons
Inventory increased 11.1%
Inventory changed +11.1% from the comparable as-filed period. The change ranks at the 24th percentile of 50 prior comparable changes.
$641.2M→$712.1M50 prior comparisons
Operating margin moved 146 bp higher
Operating margin changed +146 basis points from the comparable as-filed period. The change ranks at the 40th percentile of 57 prior comparable changes.
17.68%→19.15%57 prior comparisons
Research & development increased 8.3%
Research & development changed +8.3% from the comparable as-filed period. The change ranks at the 67th percentile of 57 prior comparable changes.
$26.4M→$28.6M57 prior comparisons
Revenue increased 7.3%
Revenue changed +7.3% from the comparable as-filed period. The change ranks at the 47th percentile of 57 prior comparable changes.
$1.4B→$1.5B57 prior comparisons
Stock-based compensation increased 7.6%
Stock-based compensation changed +7.6% from the comparable as-filed period. The change ranks at the 30th percentile of 33 prior comparable changes.
$11.9M→$12.8M33 prior comparisons
Gross margin moved 69 bp higher
Gross margin changed +69 basis points from the comparable as-filed period. The change ranks at the 47th percentile of 57 prior comparable changes.
45.14%→45.84%57 prior comparisons
Selling, general & administrative increased 4.5%
Selling, general & administrative changed +4.5% from the comparable as-filed period. The change ranks at the 21th percentile of 57 prior comparable changes.
$353.8M→$369.7M57 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.